Mar 31, 2021
- FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
- The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
- BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
- Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
- Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test